Hydroxyethyl Starch 130/0.4 Inhibits Production of Plasma Proinflammatory Cytokines and Attenuates Nuclear Factor-κB Activation and Toll-Like Receptors Expression in Monocytes During Sepsis

2010 ◽  
Vol 160 (1) ◽  
pp. 133-138 ◽  
Author(s):  
Junran Xie ◽  
Ran Lv ◽  
Lina Yu ◽  
Weidong Huang
Planta Medica ◽  
2021 ◽  
Author(s):  
Mengqin Hong ◽  
Xingyu Fan ◽  
Shengxiang Liang ◽  
Wang Xiang ◽  
Liting Chen ◽  
...  

AbstractRheumatoid arthritis is a chronic autoimmune disease characterized by the infiltration of synovial inflammatory cells and progressive joint destruction. Total flavonoids of Bidens pilosa have been used against inflammation in rheumatoid arthritis, but its role in bone destruction remains to be explored. The aim of this paper was to study whether total flavonoids of B. pilosa relieve the severity of collagen-induced arthritis in rats, particularly whether it regulates the production of proinflammatory cytokines and the receptor activator of nuclear factor-κB/receptor activator of nuclear factor-κB ligand/osteoprotegerin signaling pathway. In this research, a collagen-induced disease model was induced in adult rats by subcutaneous injection of collagen II. Total flavonoids of B. pilosa at different doses (40, 80, and 160 mg/kg/d) were administered intragastrically, while methotrexate (1 mg/kg/w) was injected intraperitoneally as a positive control. Paw swelling, arthritis score, and body weight were assessed and evaluated. The severity of joint damage was determined using X-ray and confirmed by histopathology. The expression levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, IL-1β, IL-17, and TNF in the serum and tissue were assayed using ELISA and immunohistochemistry. We found that total flavonoids of B. pilosa attenuated collagen-induced arthritis at the macroscopic level, and total flavonoids of B. pilosa-treated rats showed reduced paw swelling, arthritis scores, and X-ray appearance of collagen-induced arthritis in addition to improved histopathological results. These findings were consistent with reduced serum and tissue receptor activator of nuclear factor-κB ligand, TNF, IL-1β, and IL-17 levels but increased osteoprotegerin levels. Our data suggest that total flavonoids of B. pilosa attenuate collagen-induced arthritis by suppressing the receptor activator of nuclear factor-κB ligand/receptor activator of nuclear factor-κB/osteoprotegerin pathway and the subsequent production of proinflammatory cytokines. In addition, total flavonoids of B. pilosa may be a promising therapeutic candidate for the management of rheumatoid arthritis.


2001 ◽  
Vol 27 (4) ◽  
pp. 751-756 ◽  
Author(s):  
Thomas Dschietzig ◽  
Christoph Richter ◽  
Gert Pfannenschmidt ◽  
Cornelia Bartsch ◽  
Michael Laule ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A307-A308 ◽  
Author(s):  
Kenta Yoshiura ◽  
Tadahito Shimada ◽  
Takahiro Mitsuhashi ◽  
Kumi Takahashi ◽  
Hideyuki Hiraishi ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 297 ◽  
Author(s):  
Nasir Javaid ◽  
Sangdun Choi

Toll-like receptors (TLRs) represent a family of pattern recognition receptors that recognize certain pathogen-associated molecular patterns and damage-associated molecular patterns. TLRs are highly interesting to researchers including immunologists because of the involvement in various diseases including cancers, allergies, autoimmunity, infections, and inflammation. After ligand engagement, TLRs trigger multiple signaling pathways involving nuclear factor-κB (NF-κB), interferon-regulatory factors (IRFs), and mitogen-activated protein kinases (MAPKs) for the production of various cytokines that play an important role in diseases like cancer. TLR activation in immune as well as cancer cells may prevent the formation and growth of a tumor. Nonetheless, under certain conditions, either hyperactivation or hypoactivation of TLRs supports the survival and metastasis of a tumor. Therefore, the design of TLR-targeting agonists as well as antagonists is a promising immunotherapeutic approach to cancer. In this review, we mainly describe TLRs, their involvement in cancer, and their promising properties for anticancer drug discovery.


Immunology ◽  
2008 ◽  
Vol 124 (4) ◽  
pp. 534-541 ◽  
Author(s):  
Pablo C. Ortiz-Lazareno ◽  
Georgina Hernandez-Flores ◽  
Jorge R. Dominguez-Rodriguez ◽  
Jose M. Lerma-Diaz ◽  
Luis F. Jave-Suarez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document